Neurothrombectomy Devices Market Size, Share, Trends, Industry Analysis Report: By Product (Clot Retrievers, Aspiration/Suction Devices, and Vascular Snares), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Afric
Description
The neurothrombectomy devices market size is expected to reach USD 1,418.33 million by 2034, according to a new study by Polaris Market Research. The report “Neurothrombectomy Devices Market Size, Share, Trends, Industry Analysis Report: By Product (Clot Retrievers, Aspiration/Suction Devices, and Vascular Snares), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The neurothrombectomy devices market focuses on medical instruments designed to remove blood clots from the brain in patients suffering from acute ischemic stroke, helping restore blood flow and prevent neurological complications. The market is experiencing significant growth due to the rising incidence of stroke globally, increasing adoption of minimally invasive procedures, and continuous technological advancements in clot retrieval and aspiration devices. Neurothrombectomy devices market opportunities are emerging in developing regions where improving healthcare infrastructure and awareness are driving demand for advanced stroke treatments. Key trends include the integration of artificial intelligence for stroke diagnosis, expanding clinical research for product innovation, and growing reimbursement support in developed markets. With increasing regulatory approvals and strategic collaborations among market players, the neurothrombectomy devices market is expected to expand further in the coming years.
Neurothrombectomy Devices Market Report Highlights
By product, the clot retrievers segment accounted for the largest share of the neurothrombectomy devices market revenue in 2024 due to their high efficacy in mechanical thrombectomy procedures, while aspiration/suction devices are expected to witness the highest growth due to advancements in vacuum-assisted clot removal technologies.
By end use, the hospitals segment dominated the neurothrombectomy devices market share as they are the primary centers for stroke treatment with well-equipped neurovascular units, while ambulatory surgical centers are experiencing rapid growth due to increasing demand for minimally invasive procedures and faster patient recovery.
North America holds the largest market share due to advanced healthcare infrastructure, high stroke incidence, and strong reimbursement policies, while Asia-Pacific is the fastest-growing region driven by rising healthcare investments, increasing awareness, and improving stroke management facilities.
A few major companies in the market are Abbott Laboratories; Acandis GmbH; AngioDynamics, Inc.; Argon Medical Devices, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Johnson & Johnson Services, Inc. (Cerenovus); LeMaitre Vascular, Inc.; Medtronic plc; MicroVention, Inc. (a subsidiary of Terumo Corporation); Penumbra, Inc.; Phenox GmbH; Stryker Corporation; Terumo Corporation; and Vesalio, LLC.
Polaris Market Research has segmented the neurothrombectomy devices market report on the basis of product, end use, and region:
By Product Outlook (Revenue – USD Million, 2020–2034)
Clot Retrievers
Aspiration/Suction Devices
Vascular Snares
By End Use Outlook (Revenue – USD Million, 2020–2034)
Hospitals
Emergency Clinics
Ambulatory Surgical Centers
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
The neurothrombectomy devices market focuses on medical instruments designed to remove blood clots from the brain in patients suffering from acute ischemic stroke, helping restore blood flow and prevent neurological complications. The market is experiencing significant growth due to the rising incidence of stroke globally, increasing adoption of minimally invasive procedures, and continuous technological advancements in clot retrieval and aspiration devices. Neurothrombectomy devices market opportunities are emerging in developing regions where improving healthcare infrastructure and awareness are driving demand for advanced stroke treatments. Key trends include the integration of artificial intelligence for stroke diagnosis, expanding clinical research for product innovation, and growing reimbursement support in developed markets. With increasing regulatory approvals and strategic collaborations among market players, the neurothrombectomy devices market is expected to expand further in the coming years.
Neurothrombectomy Devices Market Report Highlights
By product, the clot retrievers segment accounted for the largest share of the neurothrombectomy devices market revenue in 2024 due to their high efficacy in mechanical thrombectomy procedures, while aspiration/suction devices are expected to witness the highest growth due to advancements in vacuum-assisted clot removal technologies.
By end use, the hospitals segment dominated the neurothrombectomy devices market share as they are the primary centers for stroke treatment with well-equipped neurovascular units, while ambulatory surgical centers are experiencing rapid growth due to increasing demand for minimally invasive procedures and faster patient recovery.
North America holds the largest market share due to advanced healthcare infrastructure, high stroke incidence, and strong reimbursement policies, while Asia-Pacific is the fastest-growing region driven by rising healthcare investments, increasing awareness, and improving stroke management facilities.
A few major companies in the market are Abbott Laboratories; Acandis GmbH; AngioDynamics, Inc.; Argon Medical Devices, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Johnson & Johnson Services, Inc. (Cerenovus); LeMaitre Vascular, Inc.; Medtronic plc; MicroVention, Inc. (a subsidiary of Terumo Corporation); Penumbra, Inc.; Phenox GmbH; Stryker Corporation; Terumo Corporation; and Vesalio, LLC.
Polaris Market Research has segmented the neurothrombectomy devices market report on the basis of product, end use, and region:
By Product Outlook (Revenue – USD Million, 2020–2034)
Clot Retrievers
Aspiration/Suction Devices
Vascular Snares
By End Use Outlook (Revenue – USD Million, 2020–2034)
Hospitals
Emergency Clinics
Ambulatory Surgical Centers
By Regional Outlook (Revenue – USD Million, 2020–2034)
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
120 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Neurostimulation Devices Market Insights
- 4.1. Neurostimulation Devices Market – Market Snapshot
- 4.2. Neurostimulation Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Neurological Disorders
- 4.2.1.2. Advancements in Neurostimulation Technology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Devices and Procedures
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurostimulation Devices Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Neurostimulation Devices Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 5.3. Pain Management
- 5.3.1. Global Neurostimulation Devices Market, by Pain Management, by Region, 2020-2034 (USD Billion)
- 5.4. Epilepsy
- 5.4.1. Global Neurostimulation Devices Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
- 5.5. Essential Tremor
- 5.5.1. Global Neurostimulation Devices Market, by Essential Tremor, by Region, 2020-2034 (USD Billion)
- 5.6. Urinary & Faecal Incontinence
- 5.6.1. Global Neurostimulation Devices Market, by Urinary & Faecal Incontinence, by Region, 2020-2034 (USD Billion)
- 5.7. Depression
- 5.7.1. Global Neurostimulation Devices Market, by Depression, by Region, 2020-2034 (USD Billion)
- 6. Global Neurostimulation Devices Market, by Devices
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 6.3. Spinal Cord Stimulator
- 6.3.1. Global Neurostimulation Devices Market, by Spinal Cord Stimulator, by Region, 2020-2034 (USD Billion)
- 6.4. Deep Brain Stimulator
- 6.4.1. Global Neurostimulation Devices Market, by Deep Brain Stimulator, by Region, 2020-2034 (USD Billion)
- 6.5. Sacral Nerve Stimulator
- 6.5.1. Global Neurostimulation Devices Market, by Sacral Nerve Stimulator, by Region, 2020-2034 (USD Billion)
- 6.6. Vagus Nerve Stimulator
- 6.6.1. Global Neurostimulation Devices Market, by Vagus Nerve Stimulator, by Region, 2020-2034 (USD Billion)
- 6.7. Gastric Electric Stimulator
- 6.7.1. Global Neurostimulation Devices Market, by Gastric Electric Stimulator, by Region, 2020-2034 (USD Billion)
- 7. Global Neurostimulation Devices Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Neurostimulation Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Neurostimulation Devices Market – North America
- 7.3.1. North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.3.2. North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.3.3. Neurostimulation Devices Market – U.S.
- 7.3.3.1. U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.3.4. Neurostimulation Devices Market – Canada
- 7.3.4.1. Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4. Neurostimulation Devices Market – Europe
- 7.4.1. Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.2. Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.3. Neurostimulation Devices Market – UK
- 7.4.3.1. UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.4. Neurostimulation Devices Market – France
- 7.4.4.1. France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.4.2. France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.5. Neurostimulation Devices Market – Germany
- 7.4.5.1. Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.6. Neurostimulation Devices Market – Italy
- 7.4.6.1. Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.7. Neurostimulation Devices Market – Spain
- 7.4.7.1. Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.8. Neurostimulation Devices Market – Netherlands
- 7.4.8.1. Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.9. Neurostimulation Devices Market – Russia
- 7.4.9.1. Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.10. Neurostimulation Devices Market – Rest of Europe
- 7.4.10.1. Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5. Neurostimulation Devices Market – Asia Pacific
- 7.5.1. Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.3. Neurostimulation Devices Market – China
- 7.5.3.1. China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.3.2. China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.4. Neurostimulation Devices Market – India
- 7.5.4.1. India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.4.2. India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.5. Neurostimulation Devices Market – Malaysia
- 7.5.5.1. Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.6. Neurostimulation Devices Market – Japan
- 7.5.6.1. Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.7. Neurostimulation Devices Market – Indonesia
- 7.5.7.1. Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.8. Neurostimulation Devices Market – South Korea
- 7.5.8.1. South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.9. Neurostimulation Devices Market – Australia
- 7.5.9.1. Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.10. Neurostimulation Devices Market – Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6. Neurostimulation Devices Market – Middle East & Africa
- 7.6.1. Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.3. Neurostimulation Devices Market – Saudi Arabia
- 7.6.3.1. Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.4. Neurostimulation Devices Market – UAE
- 7.6.4.1. UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.5. Neurostimulation Devices Market – Israel
- 7.6.5.1. Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.6. Neurostimulation Devices Market – South Africa
- 7.6.6.1. South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.7. Neurostimulation Devices Market – Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7. Neurostimulation Devices Market – Latin America
- 7.7.1. Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.3. Neurostimulation Devices Market – Mexico
- 7.7.3.1. Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.4. Neurostimulation Devices Market – Brazil
- 7.7.4.1. Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.5. Neurostimulation Devices Market – Argentina
- 7.7.5.1. Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.6. Neurostimulation Devices Market – Rest of Latin America
- 7.7.6.1. Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Advanced Bionics (a Sonova Group company)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Aleva Neurotherapeutics
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Cochlear Limited
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Cognito Therapeutics
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. ElectroCore, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Inspire Medical Systems, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. LivaNova PLC
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Medtronic plc
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
